Back | Next |
home / stock / nnvc / nnvc message board
Subject | By | Source | When |
---|---|---|---|
Up 11+% today, but I wonder how long | drkazmd65 | investorshub | 04/05/2023 3:58:12 PM |
Incredible for sure. Don't know how I missed | loanranger | investorshub | 04/04/2023 2:48:42 PM |
Yep - not surprising at all that Diwan | drkazmd65 | investorshub | 04/04/2023 2:24:38 PM |
https://www.karveermeditech.com/ "Growing to Care. Founder: Dr. Anil Diwan" | KMBJN | investorshub | 04/04/2023 1:51:48 PM |
It about time - And good to see | drkazmd65 | investorshub | 04/04/2023 12:37:22 PM |
Directors of Karveer Meditech Private Limited are Vivek | loanranger | investorshub | 04/02/2023 9:45:36 PM |
A Big Lie right in the headline: | loanranger | investorshub | 04/02/2023 9:24:51 PM |
Makes good sense. | arvitar | investorshub | 03/17/2023 3:41:00 PM |
Yeah - I don't really pay much attention | drkazmd65 | investorshub | 03/14/2023 6:57:28 PM |
Good grief. | arvitar | investorshub | 02/16/2023 9:07:12 PM |
Got out of this a long time ago! | Deep6 | investorshub | 02/15/2023 11:26:02 PM |
Indeed - the wording is - as usual | drkazmd65 | investorshub | 02/15/2023 4:38:35 PM |
We are working diligently towards the goal of | loanranger | investorshub | 02/15/2023 4:05:04 PM |
Some Highlights From the 10Q Heres hoping | drkazmd65 | investorshub | 02/15/2023 2:45:30 PM |
Cest la vie? | drkazmd65 | investorshub | 02/14/2023 2:28:39 PM |
They needed 8.033M votes and they got 8.115M, | loanranger | investorshub | 02/14/2023 2:37:16 AM |
Guess who's moving their domicile to Delaware! | loanranger | investorshub | 02/14/2023 2:12:51 AM |
Good grief...16 years later, and folks are still | arvitar | investorshub | 02/13/2023 10:07:24 PM |
Incorrect. But thanks for participating in the | drkazmd65 | investorshub | 02/13/2023 2:45:05 PM |
There is absolutely no similarity between what is | arvitar | investorshub | 02/10/2023 5:49:28 PM |
News, Short Squeeze, Breakout and More Instantly...
SHELTON, CT / ACCESSWIRE / July 11, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, discusses its development program for NV-387, a single drug that has shown activity against many respiratory viral infe...
SHELTON, CT / ACCESSWIRE / July 1, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its current assets and plans towards becoming a successful pharmaceutical company intending to revolutioni...
--News Direct-- NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share promising news about the company's ultra-broad-spectrum antiviral, NV-387. The antiviral was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse mod...